An insightful, collaborative, and creative leader, Leo carries more than 25 years of deep cross-functional commercial and clinical development experience across both biologics and small molecules. He has built and shaped brands across multiple therapeutic areas, with particular expertise in a specialty and rare disease/Orphan Drug markets across all phases of the product lifecycle. Core therapeutic areas of expertise include neuroscience, oncology, immunology, cardiovascular, and GI, as well as biomarkers.
His proven record of success spans global marketing, business development, negotiations, and alliance capability building and leadership. This unique cross-functional perspective enables Leo to look at challenges holistically and to critically and thoughtfully assess scientific differentiation, major market drivers, strategies, and tactics vital to building enduring competitive advantage. And, his science-driven, market-led, patient-focused approach maximizes product value to patients, clinicians, and payers through its lifecycle.
Prior to founding his own biopharma commercialization consulting practice, StraNexa LLC, Leo held various leadership roles across marketing, business development, and alliance leadership at leading firms such as AstraZeneca, Merck, Astra Merck, and Regeneron. Leo earned an MBA from Harvard Business School (fellowship), a BS in Business Administration from West Virginia University (summa cum laude; Rhodes Scholarship Finalist), and executive leadership certifications from Northwestern University (Kellogg) and University of Pennsylvania (Wharton). He also completed extensive coursework in biological sciences (Villanova University/Bucks CC), earning high honors (Phi Theta Kappa distinction), and a graduate of the HMX Program at Harvard Medical School (immuno-oncology, pharmacology, and immunology). In addition, he is an expert instructor for Biotech Primer, facilitating a course he created covering important concepts within strategic commercialization in biopharmaceuticals, as well as facilitating its Drug Development Immersion course. Leo also serves as a volunteer Strategic Projects Director for the Castleman Disease Collaborative Network (CDCN) and is a co-founder and strategic advisor to the Camden Dream Center, a non-profit community organization dedicated to empowering inner-city families with education and career pathways.